Pasar al contenido principal

Investigación y educación

Enviado por remote_content el

Diaz A. Quantitative sensory testing: a good tool to identify subclinical neuropathy in ATTRV30M amyloidosis patients? Amyloid.

Investigación y Educación

"Background Quantitative sensory testing (QST) has been one of the neurophysiological tools used for follow-up and disease progression assessment in ATTRv amyloidosis. We aimed to detect the utility of QST in identifying subclinical neuropathic involvement in ATTRV30M amyloidosis carriers.

Conclusions QST, in particular CDT, HP 5 and HP 0.5 modalities, seems a good tool to identify subclinical neuropathy in ATTRv amyloidosis carriers, with CDT showing a higher sensitivity to detect and early neuropathic involvement."

Read full article

Artículos que te pueden interesar

Neurología

"Frequency of NMOSD misdiagnosis in a cohort from Latin America: Impact and evaluation of different contributors. Mult Scler. 2022 Dec"

Diciembre 1, 2022

Leer más

Neurología

"on behalf research priorities LACTRIMS Working Group. Research priorities in multiple sclerosis in Latin America: A multi- stakeholder call to action to improve patients care: Research priorities in MS in LATAM. Mult Scler Relat Disord."

Mayo 24, 2021

Leer más

Neurología

"Radiofrequency Treatment of Iliac and Paravertebral Cluneal Nerves for Low Back Pain. Pain Physician."

Octubre 25, 2022

Leer más